AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,983,000 | -35.8% | 369,134 | -22.2% | 1.58% | -43.3% |
| Q3 2021 | $4,649,000 | +72.8% | 474,368 | +18.7% | 2.80% | +51.2% |
| Q2 2021 | $2,690,000 | -58.2% | 399,776 | -43.9% | 1.85% | -44.5% |
| Q1 2021 | $6,440,000 | +0.9% | 712,371 | -25.5% | 3.33% | +14.4% |
| Q4 2020 | $6,385,000 | +143.2% | 955,856 | +83.5% | 2.91% | +72.6% |
| Q3 2020 | $2,625,000 | -39.1% | 520,830 | -2.4% | 1.69% | -48.9% |
| Q2 2020 | $4,312,000 | – | 533,632 | – | 3.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |